T. Sirijindalert et al. / Tetrahedron 66 (2010) 5161e5167
5165
a colorless oil (564 mg, 55%) as a cis-isomer; Rf (10% EtOAc/hexane)
0.50; nmax (neat) 3307, 3054, 3031, 2982, 1667, 1628, 1598, 1488,
mixture was stirred overnight at room temperature under nitrogen
atmosphere. After the solution was quenched with ice, distilled
deionized water (25 mL) was added and the mixture was extracted
with CH2Cl2 (25 mL). The organic potions were combined and neu-
tralized by addition of 0.1 M aq NaHCO3 solution. The organic phase
was washed three times with deionized water (3ꢂ25 mL), dried over
Na2SO4, and evaporated under reduced pressure. The crude product
was purified by column chromatography (EtOAc/hexane¼1:50 to
1:3) to provide the corresponding dihydropyridines 6, 8aed.
1453, 1242, 1190 cmꢁ1
; dH (400 MHz, CDCl3): 9.92 (1H, d (br), J
11.7 Hz, NH), 7.36e7.18 (3H, m, ]CHN and ortho-C6H5), 7.05e6.88
(3H, m, meta-C6H5 and para-C6H5), 4.85 (1H, d, J 8.3 Hz, CH]CHN),
4.19 (2H, q, J 7.1 Hz, OCH2), 1.31 (3H, t, J 7.1 Hz, OCH2CH3); dC
(100 MHz, CDCl3): 170.3, 142.9, 140.6, 129.6 (2C), 122.4, 115.2 (2C),
87.3, 59.2, 14.4; HRMS (ESI): MNaþ, found 214.0715. C11H13NNaOþ2
requires 214.0838.
4.4.2. Ethyl-3-(4-methoxyphenylamino)acrylate (7f). Synthesized
according to above procedure 4.4 from 4-methoxyaniline (500 mg,
4.05 mmol) as a yellow oil (296 mg, 33%) as a cis-isomer; Rf (17%
EtOAc/hexane) 0.38; nmax (neat) 3274, 3073, 3037, 2976, 2950, 1615,
4.5.1. Diethyl-1-(2,2-dimethoxyethyl)-4-(2-ethoxy-2-oxoethyl)-1,4-
dihydropyridine-3,5-dicarboxylate (6). Synthesized according to
above general procedure 4.5 from ethyl-3-(2,2-dimethox-
yethylamino)acrylate 1b (577 mg, 2.84 mmol) as a pale yellow oil
(33 mg, 81%); Rf (25% EtOAc/hexane) 0.38; nmax (neat) 2981, 2934,
1589, 1508, 1482, 1277, 1164 cmꢁ1
; dH (400 MHz, CDCl3): 9.81 (1H,
d (br), J 12.6 Hz, NH), 7.15 (1H, dd, J 12.8, 8.3 Hz, ]CHN), 6.91 (2H, d,
J 9.0 Hz, meta-C6H4), 6.85 (2H, d, J 9.0 Hz, ortho-C6H4), 4.77 (1H, d, J
8.2 Hz, CH]CHN), 4.17 (2H, q, J 7.1 Hz, OCH2CH3), 3.78 (3H, s, OMe),
1.30 (3H, t, J 7.1 Hz, OCH2CH3); dC (100 MHz, CDCl3): 170.5, 155.4,
144.1, 134.4, 116.9 (2C), 114.9 (2C), 86.0, 59.1, 55.5, 14.5; HRMS (ESI):
MNaþ, found 244.0828. C12H15NNaOþ3 requires 244.0944.
1731, 1705, 1583, 1415, 1250, 1184, 1079 cmꢁ1
; dH (400 MHz, CDCl3):
7.15 (2H, s, CH]C), 4.39 (1H, t, J 5.1 Hz, CH(OMe)2), 4.23e4.16 (5H,
m, DHPeCO2CH2CH3 and CHCH2CO2Et), 4.03 (2H, q, J 7.1 Hz,
CH2CO2CH2CH3), 3.43 (6H, s, OMe), 3.37 (2H, d, J 5.1 Hz, NCH2), 2.47
(2H, d, J 5.0 Hz, CH2CO2Et), 1.29 (6H, t, J 7.1 Hz, DHPeCO2CH2CH3),
1.21 (3H, t, J 7.1 Hz, CH2CO2CH2CH3); dC (100 MHz, CDCl3): 171.7,
166.9 (2C), 139.8 (2C), 106.1 (2C), 103.4, 60.1 (2C), 59.9, 56.4, 55.1
(2C), 40.7, 29.2, 14.4 (2C), 14.1; HRMS (ESI): MHþ, found 400.1971.
C19H30NOþ8 requires 400.1967.
4.4.3. (Z)-Ethyl-3-(4-iodophenylamino)acrylate (7g). In this case,
synthesized according to above procedure 4.4 from 4-iodoaniline
(1.01 g, 4.61 mmol) in CH2Cl2 solution at room temperature as
a white solid (1.21 g, 83%) as a cis-isomer; mp 90e95 ꢀC; Rf (20%
EtOAc/hexane) 0.50; nmax (neat) 3294, 3084, 2971, 1666, 1625, 1584,
4.5.2. Diethyl-1-butyl-4-(2-ethoxy-2-oxoethyl)-1,4-dihydropyridine-
3,5-dicarboxylate (8a). Synthesized according to above general
procedure 4.5 from ethyl-3-(butylamino)acrylate 7a (450 mg,
2.63 mmol) as a pale yellow oil (262 mg, 81%); Rf (25% EtOAc/hex-
ane) 0.28; nmax (neat) 2975, 2957, 2932, 1731, 1699, 1580, 1196,
1470, 1196 cmꢁ1
; dH (400 MHz, CDCl3): 9.89 (1H, d (br), J 11.6 Hz,
NH), 7.57 (2H, d, J 8.7 Hz, meta-C6H4), 7.17 (1H, dd, J 12.5, 8.4 Hz, ]
CHN), 6.73 (2H, d, J 8.7 Hz, ortho-C6H4), 4.87 (1H, d, J 8.4 Hz, CH]
CHN), 4.17 (2H, q, J 7.1 Hz, OCH2), 1.30 (3H, t, J 7.1 Hz, OCH2CH3); dC
(100 MHz, CDCl3): 170.2, 142.2, 140.4, 138.4(2C), 117.2(2C), 88.4,
84.6, 59.4, 14.4; HRMS (ESI): MHþ, found 317.9985. C12H15NNaOþ3
requires 317.9986.
1081 cmꢁ1
; dH (400 MHz, CDCl3): 7.12 (2H, s, CH]C), 4.23e4.15 (5H,
m, DHPeCO2CH2CH3 and CHCH2CO2Et), 4.03 (2H, q, J 7.1 Hz,
CH2CO2CH2CH3), 3.30 (2H, t, J 7.2 Hz, NCH2), 2.45 (2H, d, J 5.0 Hz,
CH2CO2Et), 1.66e1.53 (2H, m, NCH2CH2), 1.41e1.31 (2H, m,
NCH2CH2CH2), 1.29 (6H, t, J 7.1 Hz, DHPeCO2CH2CH3), 1.20 (3H, t, J
7.2 Hz, CH2CO2CH2CH3), 0.95 (3H, t, J 7.3 Hz, N(CH2)3CH3); dC
(100 MHz, CDCl3): 171.7, 166.9 (2C), 139.3 (2C), 105.7 (2C), 60.0 (2C),
59.9, 54.7, 40.9, 32.3, 29.5, 19.5, 14.4 (2C), 14.1, 13.6; HRMS (ESI):
MNaþ, found 390.1887. C19H29NNaOþ6 requires 390.1887.
4.4.4. Ethyl-3-(4-fluorophenylamino)acrylate
(7h). Synthesized
according to above procedure 4.4 from 4-fluoroaniline (500 mg,
4.50 mmol) as a yellow solid (556 mg, 59%) as a cis-isomer; mp
35e38 ꢀC; Rf (10% EtOAc/hexane) 0.50; nmax (neat) 3305, 3275,
3071, 3948, 2980, 1665, 1624, 1600, 1509, 1478, 1197 cmꢁ1
; dH
(400 MHz, CDCl3): 9.87 (1H, d (br), J 11.5 Hz, NH), 7.15 (1H, dd, J 12.6,
8.3 Hz, ]CHN), 7.06e6.95 (2H, m, meta-C6H4), 6.95e6.85 (2H, m,
ortho-C6H4), 4.82 (1H, d, J 8.3 Hz, CH]CHN), 4.17 (2H, q, J 7.1 Hz,
OCH2CH3),1.34e1.27 (3H, m, OCH2CH3); dC (100 MHz, CDCl3): 170.4,
158.5 (d, J 241.3 Hz, CF), 143.4, 137.0, 116.7 (2C, d, J 7.9 Hz, CFCHCH),
116.3 (2C, d, J 23.0 Hz, CFCH), 87.3, 59.3, 14.4; HRMS (ESI): MNaþ,
found 232.0663. C11H12FNNaOþ2 requires 232.0744.
4.5.3. Diethyl-4-(2-ethoxy-2-oxoethyl)-1-octadecyl-1,4-dihydropyr-
idine-3,5dicarboxylate (8b). Synthesized according to above gen-
eral procedure 4.5 from ethyl-3-(octadecylamino)acrylate 7b
(318 mg, 0.87 mmol) as a pale yellow oil (134 mg, 83%); Rf (25%
EtOAc/hexane) 0.20; nmax (neat) 2929, 2850, 1736, 1697, 1211, 1175,
1072 cmꢁ1
; dH (400 MHz, CDCl3): 7.12 (2H, s, CH]C), 4.23e4.15 (5H,
m, DHPeCO2CH2CH3, and CHCH2CO2Et), 4.02 (2H, q, J 7.1 Hz,
CH2CO2CH2CH3), 3.28 (2H, t, J 7.3 Hz, NCH2), 2.45 (2H, d, J 5.0 Hz,
CH2CO2Et), 1.65e1.55 (2H, m, NCH2CH2), 1.43e1.11 (39H, m,
DHPeCO2CH2CH3, and CH2CO2CH2CH3 and N-(CH2)2(CH2)15CH3),
0.87 (3H, t, J 6.8 Hz, N(CH2)17CH3); dC (100 MHz, CDCl3): 171.7, 166.9
(2C), 139.3 (2C), 105.7 (2C), 60.0 (2C), 59.9, 54.9, 40.9, 31.9, 30.3,
29.8e29.6 (11C, br), 29.5, 29.3, 26.2, 22.7, 14.4 (2C), 14.2, 14.1; HRMS
(ESI): MHþ, found 564.4259. C33H58NOþ6 requires 564.4259.
4.4.5. Ethyl-3-(3-chlorophenylamino)acrylate
(7i). Synthesized
according to above procedure 4.4 from 3-chloroaniline (411 mg,
3.22 mmol) as a yellow solid (392 mg, 54%) as a cis-isomer; mp
51e52 ꢀC; Rf (10% EtOAc/hexane) 0.48; nmax (neat) 3067, 2982, 2927,
2898, 1670, 1635, 1599, 1469, 1203 cmꢁ1
; dH (400 MHz, CDCl3): 9.91
(1H, d (br), J 11.8 Hz, NH), 7.19 (2H, td, J 12.5, 7.2 Hz, ]CHN and 2-
ArH), 6.95 (2H, d, J 6.7 Hz, 4-ArH and 6-ArH), 6.81 (1H, d, J 7.8 Hz, 5-
ArH), 4.88 (1H, d, J 8.4 Hz, CH]CHN), 4.18 (2H, q, J 7.1 Hz, OCH2),
1.30 (3H, t, J 7.1 Hz, OCH2CH3); dC (100 MHz, CDCl3): 170.2, 142.2,
141.9, 135.4, 130.6, 122.3, 115.1, 113.6, 88.7, 59.5, 14.4; HRMS (ESI):
MNaþ, found 248.0346. C11H1235ClNNaOþ2 requires 248.0449.
4.5.4. Diethyl-1-benzyl-4-(2-ethoxy-2-oxoethyl)-1,4-dihydropyr-
idine-3,5-dicarboxylate (8c). Synthesized according to above gen-
eral procedure 4.5 from ethyl-3-(benzylamino)acrylate 7c (401 mg,
1.95 mmol) as apaleyellowoil (207 mg, 79%); Rf (25%EtOAc/hexane)
0.25; nmax (neat) 3060, 3029, 2979, 2928,1731,1698,1582,1241,1186,
4.5. Preparation of 1,4-dihydropyridines (6, 8aei)
1077 cmꢁ1
; dH (400 MHz, CDCl3): 7.47e7.21 (5H, m, Ph), 7.19 (2H, s,
CH]C), 4.50 (2H, s, NCH2), 4.23e4.13 (5H, m, DHPeCO2CH2CH3, and
CHCH2CO2Et), 3.99 (2H, q, J 7.1 Hz, CH2CO2CH2CH3), 2.50 (2H, d, J
5.0 Hz, CH2CO2Et),1.27 (6H, t, J 7.1 Hz, DHPeCO2CH2CH3),1.16 (3H, t, J
7.1 Hz, CH2CO2CH2CH3); dC (100 MHz, CDCl3): 171.7,166.7 (2C),139.4
(2C), 129.0 (2C), 128.2 (2C), 127.1, 109.9, 106.4 (2C), 60.1 (2C), 59.9,
To a solution of N-substituted
dried CH2Cl2 (0.1 M) in an ice bath, TiCl4 (0.2 equiv in the case of N-
b-amino acrylates 7 (1 equiv) in
aliphatic
aromatic
b
b
-amino acrylates 1b and 7aed or 0.5 equiv in the case of N-
-amino acrylates 7eei) was added rapidlyand the reaction